Literature DB >> 2960515

The effect of heparin and fibrin on the enzymatic efficiencies of thrombolytics in vitro.

R Fears1.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2960515     DOI: 10.2165/00003495-198700333-00009

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  10 in total

1.  Study on the mechanism of action of heparin and related substances on the fibrinolytic system: relationship between plasminogen activators and heparin.

Authors:  E P Pâques; H A Stöhr; N Heimburger
Journal:  Thromb Res       Date:  1986-06-15       Impact factor: 3.944

2.  The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasma.

Authors:  R Fears; H Ferres; R Standring
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

4.  Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.

Authors:  C Zamarron; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

5.  Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.

Authors:  W Nieuwenhuizen; A Vermond; M Voskuilen; D W Traas; J H Verheijen
Journal:  Biochim Biophys Acta       Date:  1983-10-17

6.  Systemic thrombolytic therapy of acute myocardial infarction?

Authors:  D Collen; M Verstraete
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

7.  Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.

Authors:  R Fears; M J Hibbs; R A Smith
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

8.  Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).

Authors:  K A Fox; S R Bergmann; B E Sobel
Journal:  Biochem Pharmacol       Date:  1984-06-15       Impact factor: 5.858

9.  Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase.

Authors:  H R Lijnen; B Van Hoef; D Collen
Journal:  Eur J Biochem       Date:  1984-11-02

10.  Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Biochemistry       Date:  1986-07-15       Impact factor: 3.162

  10 in total
  2 in total

1.  Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitro.

Authors:  R Fears; H Ferres; R Standring
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Authors:  H Ferres
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.